Literature DB >> 8966090

[Examination of very long chain fatty acids in diagnosis of x-linked adrenoleukodystrophy].

T J Stradomska1, A Tylki-Szymańska.   

Abstract

X-linked adrenoleukodystrophy (X-ALD) (McKusick 300100) is a relatively common disorder due to activity deficiency of a peroxisomal transporter of very long chain acyl-CoA synthetase it causes accumulation of endogenous and exogenous saturated very long chain fatty acids (VLCFA) in plasma and in all tissues. X-ALD is characterised by phenotypic variability, about 80% of patients present more or less progressive demyelinization and adrenal insufficiency. The remaining patients have isolated adrenocortical insufficiency or are asymptomatic or presymptomatic. The measurement of VLCFA accumulation in plasma using the GC-MS method is the basis of diagnosis of X-ALD. Among 162 plasma samples from patients suspected of X-ALD, only 2 were from patients suspected of adrenomyeloneuropathy (AMN). In the analysed material we identified 13 X-ALD hemizygotes and 7 X-ALD heterozygotes. Twelve patients presented the childhood cerebral form of X-ALD. VLCFA profiles in plasma were analysed in 6 patients who were on a diet and Lorenzo oil.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8966090

Source DB:  PubMed          Journal:  Pediatr Pol        ISSN: 0031-3939


  4 in total

1.  Mild Zellweger syndrome due to a novel PEX6 mutation: correlation between clinical phenotype and in silico prediction of variant pathogenicity.

Authors:  Małgorzata Rydzanicz; Teresa Joanna Stradomska; Elżbieta Jurkiewicz; Ewa Jamroz; Piotr Gasperowicz; Grażyna Kostrzewa; Rafał Płoski; Anna Tylki-Szymańska
Journal:  J Appl Genet       Date:  2017-10-18       Impact factor: 3.240

2.  Clinical profile of adrenoleukodysrophy.

Authors:  Shrikrishna V Acharya; Raju A Gopal; Tushar R Bandgar; Shashank R Joshi; Padma S Menon; Nalini S Shah
Journal:  Indian J Pediatr       Date:  2009-11-12       Impact factor: 1.967

3.  Mild form of Zellweger Spectrum Disorders (ZSD) due to variants in PEX1: Detailed clinical investigation in a 9-years-old female.

Authors:  Maria Rosaria Barillari; Marianthi Karali; Valentina Di Iorio; Maria Contaldo; Vincenzo Piccolo; Maria Esposito; Giuseppe Costa; Giuseppe Argenziano; Rosario Serpico; Marco Carotenuto; Gerarda Cappuccio; Sandro Banfi; Paolo Melillo; Francesca Simonelli
Journal:  Mol Genet Metab Rep       Date:  2020-06-20

4.  Mild Zellweger syndrome due to functionally confirmed novel PEX1 variants.

Authors:  Patryk Lipiński; Piotr Stawiński; Małgorzata Rydzanicz; Maria Wypchło; Rafał Płoski; Teresa Joanna Stradomska; Elżbieta Jurkiewicz; Sacha Ferdinandusse; Ronald J A Wanders; Frederic M Vaz; Anna Tylki-Szymańska
Journal:  J Appl Genet       Date:  2019-10-18       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.